Detransitioner Bill of Rights
With the spike increase of gender detransition lawsuits, there needs to be laws addressing what happens now.
Detransitioner’s Rights
Detransition Regret is spiking. What are the rights of children who detransition after medical intervention?
As stated below, “There is also a concerning lack of treatment guidelines for the medical care of detransitioners. In the absence of a protocol for the treatment of detransitioners, individuals undergoing detransition experience unmet healthcare needs.”
Medical Nonprofit Organization Do No Harm Introduces Detransitioner Bill of Rights
I found this proposed model legislation on Daily Wire.
Detransitioner Bill of Rights
The Detransitioner-Bill-of-Rights is attached here. I cite some notable sections below.
Medical Professional Obligations
Medical professionals should:
(1) Publicly acknowledge the growing and concerning phenomenon of detransitioners;
(2) Research ways to help detransitioners and those who regret undergoing gender transition procedures; and
(3) Develop evidence-based standards for treating detransitioners and supporting detransitioners as well as those who regret undergoing gender transition procedures.
Detransition Awareness Day
Detransition Awareness Day Set for March 12.
Definitions
“Detransitioner” means (1) an individual who began or completed a gender transition procedure but later sought treatment to reverse the effects of the gender transition procedure due to the resolution of any inconsistency between the individual’s sex and the individual’s perceived sex or perceived gender, or (2) an individual who began a gender transition procedure but has ceased that procedure due to the resolution of any inconsistency between the individual’s sex and the individual’s perceived sex or perceived gender.
“Detransition procedure” means any treatment, including mental-health treatment, medical interventions, and surgeries that (1) stop or reverse the effects of a prior gender transition procedure due to the resolution of any inconsistency between the individual’s sex and the individual’s perceived sex or perceived gender, or (2) help an individual cope with the effects of a prior gender transition procedure after the resolution of any inconsistency between the individual’s sex and the individual’s perceived sex or perceived gender.
Informed Consent
(a) No healthcare professional or physician may provide pharmaceutical or surgical treatment to minors to address an inconsistency between the minor’s sex and the minor’s perceived gender or perceived sex unless the healthcare professional or physician has obtained informed consent from the minor and the minor’s parent(s) or legal guardian(s).
(b) For purposes of this section, informed consent for any treatment requires both verbal and written notice in at least 14-point, proportionally spaced typeface of the following facts, verbatim, during every single medical visit for treatment, for a period of no less than 12 months:
(1) No reliable studies have shown that these treatments reduce the risk of suicide in children or adolescents with gender dysphoria.
(2) The Federal Food & Drug Administration has not approved the use of puberty blockers or cross-sex hormones for the purpose of treating gender dysphoria or gender incongruence. In other words, using these medications to treat gender dysphoria or gender incongruence is considered “off-label” use because they are not being used for their approved purpose.
(3) European governments, including the United Kingdom, Sweden, and Finland, have studied these treatments and have concluded there is no reliable evidence showing that the potential benefits of puberty blockers and cross-sex hormones for this purpose outweigh the risks. Those governments instead recommend psychotherapy as the first line of treatment for children and adolescents with gender dysphoria.
(4) The use of puberty blockers and cross-sex hormones for this purpose increases the risk of your child or adolescent being sterilized, meaning that he or she will never be able to have children.
(5) The use of puberty blockers and cross-sex hormones for this purpose carry numerous other risks of physical harm, including severely decreased bone density, heart disease, stroke, and cancer.
(6) The effect of these treatments on the brain development of your child or adolescent is entirely unknown.
Insurance Coverage
Any gender clinic that uses State funds to directly or indirectly provide or pay for the performance of gender transition procedures must, as a condition of receiving such funds, agree to provide or pay for the performance of detransition procedures.
If any insurance policy includes coverage for gender transition procedures, the policy must also include coverage for detransition procedures.
If any healthcare professional or physician fails to comply with this Section:
(1) The healthcare professional or physician has engaged in unprofessional conduct and is subject
to discipline by the appropriate licensing entity or disciplinary review board with competent
jurisdiction in this state. That discipline must include suspension of the ability to administer
healthcare or practice medicine for at least one year.
(2) The gender clinic where the healthcare professional or physician is employed shall pay a civil fine
not to exceed [[$250,000].
Recent Comments